IQV Q2 2024 Earnings — IQVIA Holdings Inc. Revenue & Financial Results | Market Cap Arena

IQVIQVIA Holdings Inc.

$30B

Q2 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$3.8B+2.3% YoY

Gross Profit

$1.1B27.7% margin

Operating Income

$548M14.4% margin

Net Income

$363M9.5% margin

EPS (Diluted)

$1.97

QoQ Revenue Growth

+2.1%

Cash Flow

Operating Cash Flow

$588M

Free Cash Flow

$445M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$26.4B

Total Liabilities

$19.7B

Stockholders' Equity

$6.7B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.8B	$3.7B	+2.3%
Gross Profit	$1.1B	$1.3B	-17.7%
Operating Income	$548M	$524M	+4.6%
Net Income	$363M	$297M	+22.2%

Revenue Segments

Research And Development Solutions

$2.1B56%

Technology And Analytics Solutions

$1.5B39%

Contract Sales And Medical Solutions

$172M5%

Geographic Segments

Americas

$1.9B49%

EMEA

$1.2B31%

Asia Pacific

$773M20%